FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1968442009> ?p ?o ?g. }

• W1968442009 endingPage "1465" @default.
• W1968442009 startingPage "1455" @default.
• W1968442009 abstract "IntroductionLoss of E-cadherin confers a poor prognosis in lung cancer patients and is associated with in vitro resistance to endothelial growth factor receptor inhibitors. Zinc finger E box-binding homeobox (ZEB)-1, the predominant transcriptional suppressor of E-cadherin in lung tumor lines, recruits histone deacetylases (HDACs) as co-repressors.MethodsNSCLC cell lines were treated with HDAC inhibitors and analyzed for E-cadherin induction, growth inhibition and apoptosis. National Cancer Institute-H157 cells expressing ectopic E-cadherin were tested for tumorigenicity in murine xenografts.ResultsWe found that treatment with MS-275, compared to vorinostat (SAHA), valproic acid or trichostatin A, was most effective in E-cadherin up-regulation and persistence in non-small cell lung cancers. As with other tumor types and HDAC inhibitors, MS-275 inhibited growth and induced apoptosis. Importantly, blocking E-cadherin induction by short hairpin RNA resulted in less inhibition by MS-275, implicating the epithelial to mesenchymal phenotype process as a contributing factor. In contrast to H460 and H661, H157 cells were resistant to E-cadherin up-regulation by HDAC inhibitors. However, E-cadherin was restored, in a synergistic manner, by combined knockdown of ZEB-1 and ZEB-2. In addition, H157 cells stably transfected with E-cadherin were markedly attenuated in their tumor forming ability. Lastly, combining MS-275 with the microtubule stabilizing agent, paclitaxel, or 17-(allylamino)-17-demethoxygeldanamycin, a heat shock protein 90 inhibitor, resulted in synergistic growth inhibition. Since MS-275 has no reported activity against HDAC6, which regulates both microtubule and heat shock protein 90 functions, other mechanisms of synergy are anticipated.ConclusionsThese results support the role of ZEB proteins and HDAC inhibitors in the pathogenesis and treatment of lung cancer." @default.
• W1968442009 created "2016-06-24" @default.
• W1968442009 creator A5026049918 @default.
• W1968442009 creator A5028629775 @default.
• W1968442009 creator A5034724598 @default.
• W1968442009 creator A5038813552 @default.
• W1968442009 creator A5051433948 @default.
• W1968442009 creator A5081654329 @default.
• W1968442009 creator A5087213703 @default.
• W1968442009 date "2009-12-01" @default.
• W1968442009 modified "2023-10-15" @default.
• W1968442009 title "Induction of E-Cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition" @default.
• W1968442009 cites W1483361659 @default.
• W1968442009 cites W1577577364 @default.
• W1968442009 cites W1963592300 @default.
• W1968442009 cites W1963684624 @default.
• W1968442009 cites W1967599173 @default.
• W1968442009 cites W1968772995 @default.
• W1968442009 cites W1969337484 @default.
• W1968442009 cites W1981752846 @default.
• W1968442009 cites W1983819128 @default.
• W1968442009 cites W1988442083 @default.
• W1968442009 cites W1992586037 @default.
• W1968442009 cites W1992740422 @default.
• W1968442009 cites W1994637279 @default.
• W1968442009 cites W2008520728 @default.
• W1968442009 cites W2020736126 @default.
• W1968442009 cites W2020830322 @default.
• W1968442009 cites W2024425375 @default.
• W1968442009 cites W2025647419 @default.
• W1968442009 cites W2027636023 @default.
• W1968442009 cites W2030092320 @default.
• W1968442009 cites W2031671750 @default.
• W1968442009 cites W2040630335 @default.
• W1968442009 cites W2043696829 @default.
• W1968442009 cites W2044303805 @default.
• W1968442009 cites W2050526044 @default.
• W1968442009 cites W2050931169 @default.
• W1968442009 cites W2051890772 @default.
• W1968442009 cites W2055145919 @default.
• W1968442009 cites W2055261266 @default.
• W1968442009 cites W2059526410 @default.
• W1968442009 cites W2067991344 @default.
• W1968442009 cites W2074974325 @default.
• W1968442009 cites W2077945404 @default.
• W1968442009 cites W2087966689 @default.
• W1968442009 cites W2089315363 @default.
• W1968442009 cites W2091685314 @default.
• W1968442009 cites W2099080235 @default.
• W1968442009 cites W2099803844 @default.
• W1968442009 cites W2100618837 @default.
• W1968442009 cites W2114468318 @default.
• W1968442009 cites W2123669549 @default.
• W1968442009 cites W2127016234 @default.
• W1968442009 cites W2142819263 @default.
• W1968442009 cites W2153899204 @default.
• W1968442009 cites W2156431946 @default.
• W1968442009 cites W2157228274 @default.
• W1968442009 cites W2167620731 @default.
• W1968442009 cites W2169409181 @default.
• W1968442009 cites W2185440705 @default.
• W1968442009 cites W4293241248 @default.
• W1968442009 doi "https://doi.org/10.1097/jto.0b013e3181bc9419" @default.
• W1968442009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2796578" @default.
• W1968442009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20009910" @default.
• W1968442009 hasPublicationYear "2009" @default.
• W1968442009 type Work @default.
• W1968442009 sameAs 1968442009 @default.
• W1968442009 citedByCount "39" @default.
• W1968442009 countsByYear W19684420092012 @default.
• W1968442009 countsByYear W19684420092013 @default.
• W1968442009 countsByYear W19684420092014 @default.
• W1968442009 countsByYear W19684420092016 @default.
• W1968442009 countsByYear W19684420092017 @default.
• W1968442009 countsByYear W19684420092018 @default.
• W1968442009 countsByYear W19684420092019 @default.
• W1968442009 countsByYear W19684420092022 @default.
• W1968442009 countsByYear W19684420092023 @default.
• W1968442009 crossrefType "journal-article" @default.
• W1968442009 hasAuthorship W1968442009A5026049918 @default.
• W1968442009 hasAuthorship W1968442009A5028629775 @default.
• W1968442009 hasAuthorship W1968442009A5034724598 @default.
• W1968442009 hasAuthorship W1968442009A5038813552 @default.
• W1968442009 hasAuthorship W1968442009A5051433948 @default.
• W1968442009 hasAuthorship W1968442009A5081654329 @default.
• W1968442009 hasAuthorship W1968442009A5087213703 @default.
• W1968442009 hasBestOaLocation W19684420091 @default.
• W1968442009 hasConcept C104317684 @default.
• W1968442009 hasConcept C173396325 @default.
• W1968442009 hasConcept C190232843 @default.
• W1968442009 hasConcept C190283241 @default.
• W1968442009 hasConcept C2776262904 @default.
• W1968442009 hasConcept C2777865847 @default.
• W1968442009 hasConcept C2778305200 @default.
• W1968442009 hasConcept C2779707156 @default.
• W1968442009 hasConcept C502942594 @default.
• W1968442009 hasConcept C54355233 @default.
• W1968442009 hasConcept C55493867 @default.

• next